📈 New purchase - CapsoVision
I am with CapsoVision an innovative MedTech company that is setting new standards with its 360° capsule endoscopy. No external recorder required, full perspective - and already FDA-approved & in use in the USA.
💡 Why this investment?
- Technological advantage compared to traditional solutions (e.g. PillCam from Medtronic)
- Already cooperating with Pentax Medical
- Focus on early detection & diagnosticsa megatrend in the healthcare sector
- Low market capitalization (~180m USD) with a lot of upside potential
🚀 Vision:
If CapsoVision reaches USD 50-100m sales in the medium term, a multiple in the share price is possible. In the long term I see 10-25 USD+ per share as realistic - depending on market penetration and access to capital, of course.
I think: exciting small cap story with disruptive potential - What do you think?
👉 Do you know the company? How do you rate the opportunities & risks?
Please leave your opinion!
#aktien
#investieren
#MedTech
#CapsoVision
#SmallCap
#langfristig
#innovation
#getquin
#medizin
#medizintechnik
#pharma
#medical
#zukunft
$NOVO B (+0,19 %)
$PLTR (-0,78 %)
$AMD (-3,44 %)
$NOVN (-0,54 %)